Document is current
Any future updates will be listed below
-
Authors
Hallal, Mahmoud
Braga-Lagache, Sophie
Jankovic, Jovana
Simillion, Cedric
Bruggmann, Rémy
Uldry, Anne-Christine
Allam, Ramanjaneyulu
Heller, Manfred
Bonadies, Nicolas https://orcid.org/0000-0001-8761-2066
-
Funding
Funding for this research was provided by:
Bernische Krebsliga
Inselspital Research Grant (84800751)
- License Information
-
More Information
Article History
Received: 8 December 2020
Accepted: 10 June 2021
First Online: 8 July 2021
Declarations
:
: Not applicable, no primary patient samples used.
: Not applicable.
: The authors declare no conflict of interest for the development and validation of the KAEA pipeline. Potentially perceived conflicts of interests according to the definitions and terms of the <i>International Committee of Medical Journal Editors</i> are <b>MH1:</b><i>Cell Signaling Technology</i>: financial support for travel; <b>SBL:</b> none; <b>JJ:</b><i>Celgene:</i> financial support for travel; <b>CS, RB, RA, ACU, MH2:</b> none; <b>NB:</b><i>Amgen:</i> financial support for travel; <i>Astellas:</i> research funding to institution; <i>Celgene/BMS:</i> advisory board, consultancy, financial support for travel, research funding to institution; <i>Janssen:</i> financial support for travel; <i>Novartis:</i> financial support for travel, research funding to institution; <i>Roche:</i> financial support for travel, research funding to institution; <i>Sandoz:</i> advisory board, research funding to institution; <i>Servier:</i> research funding to institution; <i>Takeda:</i> advisory board.
